A Randomized, Double-Blinded, Placebo-Controlled Trial of Homeopathy in Acute Viral Tonsillitis in Children.
Sourav De, Shubhamoy Ghosh, Satadal Das et al.
✦ AI-curated · Sources linked
In 30 seconds
This single-centre, double-blind, randomized, placebo-controlled trial evaluated individualized homeopathic medicines (IHMs), added to supportive care, in 78 children with acute viral tonsillitis. Compared with placebo, IHMs produced a greater reduction in Tonsillopharyngitis assessment scores by day 3 (adjusted mean difference -2.01, 95% confidence interval -2.78 to -1.24; p < 0.001). Meaningful recovery at day 3 occurred in 88.5% vs. 38.5%, and median time to sore throat remission and complete clinical recovery was 3.0 vs. 4.8 days. The authors report that results were robust across sensitivity and multiplicity-adjusted analyses.
Key findings
- At day 3, the adjusted mean difference in Tonsillopharyngitis assessment score was -2.01 (95% confidence interval -2.78 to -1.24; p < 0.001) in favour of IHMs.
- Meaningful recovery at day 3 was reported in 88.5% with IHMs vs. 38.5% with placebo; the reported number needed to treat was 2.0.
- Median time to sore throat remission and complete clinical recovery was 3.0 vs. 4.8 days; both comparisons had p < 0.001.
Why it matters
The trial reports improvements in an objective tonsillopharyngitis score and recovery outcomes when individualized homeopathic medicines were added to supportive care. These findings may be relevant to discussions of adjunctive approaches for childhood acute viral tonsillitis, while interpretation should account for the single-centre setting and the need for evidence beyond this trial.
What to keep in mind
The trial was conducted in a single-centre outpatient pediatric setting and enrolled 78 children, limiting the breadth of the evidence.